Treovir
0 followers
‌
Treovir’s G207 Therapy demonstrated improved survival in a Phase 1 study without any serious side effects. Treovir strives to change the course of brain tumor therapies, improve survival rates and quality of life and provide hope.
Industries
Headquarters
Employees
Links
Org chart
Michael Christini
Founder & CEO
